Amvis Holdings (TSE:7071) ROE %: 8.72% (As of Mar. 2026) — 68% Below Median


TSE:7071 Amvis Holdings Inc TSE:7071
78 GF Score
Price 円375.00
GF Value 円1,189.00
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Amvis Holdings ROE %?

Amvis Holdings TSE:7071 +5.34% 78 ROE % is 8.72% as of Mar. 2026, which is 68% below its 10-year median of 26.86. GuruFocus rates TSE:7071 with a GF Score™ of 78/100 and a GF Value™ of 円1,189.00 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 623 Healthcare Providers & Services companies, Amvis Holdings ranks better than 56.82% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Amvis Holdings's annualized net income for the quarter that ended in Mar. 2026 was 円3,260 Mil. Amvis Holdings's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was 円37,385 Mil. Therefore, Amvis Holdings's annualized ROE % for the quarter that ended in Mar. 2026 was 8.72%.

The historical rank and industry rank for Amvis Holdings's ROE % or its related term are showing as below:

TSE:7071' s ROE % Range Over the Past 10 Years
Min: 7.9   Med: 26.86   Max: 88.69
Current: 7.9

During the past 9 years, Amvis Holdings's highest ROE % was 88.69%. The lowest was 7.90%. And the median was 26.86%.

TSE:7071's ROE % is ranked better than
56.82% of 623 companies
in the Healthcare Providers & Services industry
Industry Median: 5.88 vs TSE:7071: 7.90

Amvis Holdings  (TSE:7071) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=3260/37384.5
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(3260 / 50656)*(50656 / 83638.5)*(83638.5 / 37384.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=6.44 %*0.6057*2.2373
=ROA %*Equity Multiplier
=3.9 %*2.2373
=8.72 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=3260/37384.5
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (3260 / 4932) * (4932 / 4824) * (4824 / 50656) * (50656 / 83638.5) * (83638.5 / 37384.5)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.661 * 1.0224 * 9.52 % * 0.6057 * 2.2373
=8.72 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Amvis Holdings ROE % Related Terms


Amvis Holdings ROE % Historical Data

* Premium members only.

The historical data trend for Amvis Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amvis Holdings ROE % Chart

Amvis Holdings Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROE %
Get a 7-Day Free Trial Premium Member Only 24.33 23.26 26.86 24.90 10.56

Amvis Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.57 3.51 7.40 11.85 8.72

TSE:7071 vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Amvis Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amvis Holdings ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Amvis Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Amvis Holdings's ROE % falls into.


TSE:7071
78GF Score
Amvis Holdings Inc TSE:7071
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amvis Holdings ROE % Calculation

Amvis Holdings's annualized ROE % for the fiscal year that ended in Sep. 2025 is calculated as

ROE %=Net Income (A: Sep. 2025 )/( (Total Stockholders Equity (A: Sep. 2024 )+Total Stockholders Equity (A: Sep. 2025 ))/ count )
=3660/( (33212+36132)/ 2 )
=3660/34672
=10.56 %

Amvis Holdings's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=3260/( (36832+37937)/ 2 )
=3260/37384.5
=8.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 8.72% mean?
Amvis Holdings (TSE:7071) has a ROE % of 8.72% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Amvis Holdings and its competitors. This is 68% below median its historical median of 26.86. Over the past decade, Amvis Holdings' ROE % has ranged from 7.90 to 88.69. According to the industry distribution chart, Amvis Holdings ranks #269 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 43.2%.
Is Amvis Holdings' ROE % too high?
Amvis Holdings' current ROE % of 8.72% is 68% below median its 10-year median of 26.86. Over the past 10 years, this metric has ranged from a low of 7.90 to a high of 88.69. The Healthcare Providers & Services industry median ROE % is 5.88. Amvis Holdings' value of 8.72% is 48.3% above this industry median. Based on the distribution chart, Amvis Holdings ranks #269 out of 623 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Amvis Holdings has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amvis Holdings' ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Amvis Holdings ranks #269 out of 623 companies for ROE %. This puts Amvis Holdings in the upper half of its industry. The industry median ROE % is 5.88. Amvis Holdings' value of 8.72% is 48.3% above this benchmark. Historically, Amvis Holdings' own ROE % has ranged from 7.90 to 88.69 over the past decade. While the company's 10-year median is 26.86 vs. the industry median of 5.88, Amvis Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amvis Holdings's current ROE % of 8.72% is 48.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Amvis Holdings and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amvis Holdings's current ROE % is 8.72%, which is 68% below median its own 10-year median of 26.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amvis Holdings stock overvalued right now?
Based on GuruFocus' analysis, Amvis Holdings (TSE:7071) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,189.00, compared to a current price of 円375.00 — trading 68.5% below its estimated fair value. The current ROE % is 8.72%, which is 68% below median its 10-year median of 26.86 and 48.3% above the Healthcare Providers & Services industry median of 5.88. Amvis Holdings' overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Amvis Holdings (TSE:7071), the current ROE % is 8.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amvis Holdings (TSE:7071) Overvalued in 2026?

Based on GuruFocus' analysis, Amvis Holdings stock appears to be undervalued. The current stock price of 円375.00 is trading 68.5% below its estimated GF Value™ of 円1,189.00. GuruFocus considers Amvis Holdings to be Possible Value Trap.

Key valuation signals for TSE:7071:

  • ROE %: 8.72% (68% below median its 10-year median of 26.86)
  • GF Value™: 円1,189.00 vs. price of 円375.00 (68.5% below fair value)
  • GF Score™: 78/100 with 5 warning signs
  • Industry Position: 48.3% above the Healthcare Providers & Services median (#269 of 623)

No single metric tells the full story. See the TSE:7071 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Amvis Holdings Business Description

Address 1-6-1 Kyobashi, Chuo-ku, Tokyo, JPN, 103-0028
Amvis Holdings Inc operates as a holding company. The company, through its subsidiaries, is engaged in home nursing care, home care support, consulting, and operational support related to the management and operation of residential nursing homes and medical facilities. The company is also engaged in the business of renting land and buildings to be used for residential, paid nursing homes, and medical centers.
78GF Score

Get the complete analysis for TSE:7071

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円375.00
Price
円1,189.00
GF Value